Risk management - a balancing act to keep competitive edge
This article was originally published in Clinica
Risk management has emerged from being just one component of the corporate planning process into a management discipline in its own right. For device companies, the basic premise is that no product should be assumed to be entirely risk-free, and effective and competitive commercial strategies need to be built around this. And at the same time, its application has spread from the commercial sector into organisations across the activity spectrum.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.